Wells Fargo & Company Abbott Laboratories Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Abbott Laboratories stock. As of the latest transaction made, Wells Fargo & Company holds 16,983,807 shares of ABT stock, worth $2 Billion. This represents 0.45% of its overall portfolio holdings.

Number of Shares

16,983,807

Previous 16,848,672 0.8%

Holding current value

$2 Billion

Previous $1.75 Billion 10.6%

% of portfolio

0.45%

Previous 0.43%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$100.07 - $118.13 $13.5 Million - $16 Million	135,135 Added 0.8%	16,983,807 $1.94 Billion
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $6.06 Million - $6.77 Million	60,181 Added 0.36%	16,848,672 $1.75 Billion
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $34.8 Million - $38.4 Million	317,587 Added 1.93%	16,788,491 $1.91 Billion
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $10.7 Million - $13.1 Million	-118,216 Reduced 0.71%	16,470,904 $1.81 Billion
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $47.4 Million - $56.8 Million	-495,913 Reduced 2.9%	16,589,120 $1.61 Billion
Q2 2023 Aug 15, 2023	SELL	$100.78 - $112.29 $17.5 Million - $19.5 Million	-173,737 Reduced 1.01%	17,085,033 $1.86 Billion
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $18.7 Million - $22 Million	192,725 Added 1.13%	17,258,770 $1.75 Billion
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $9.04 Million - $10.6 Million	-95,107 Reduced 0.55%	17,066,045 $1.87 Billion
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $1.27 Million - $1.47 Million	-13,164 Reduced 0.08%	17,161,152 $1.66 Billion
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $60.7 Million - $73.4 Million	-594,858 Reduced 3.35%	17,174,316 $1.87 Billion
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $52.1 Million - $63.5 Million	456,615 Added 2.64%	17,769,174 $2.1 Billion
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $136 Million - $167 Million	-1,179,202 Reduced 6.38%	17,312,559 $2.44 Billion
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $27 Million - $29.9 Million	-231,304 Reduced 1.24%	18,491,761 $2.18 Billion
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $126 Million - $148 Million	-1,188,031 Reduced 5.97%	18,723,065 $2.17 Billion
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $16 Million - $18.8 Million	-146,757 Reduced 0.73%	19,911,096 $2.39 Billion
Q4 2020 Feb 09, 2021	BUY	$105.0 - $114.42 $36.2 Million - $39.5 Million	344,805 Added 1.75%	20,057,853 $2.2 Billion
Q3 2020 Nov 05, 2020	SELL	$91.64 - $111.29 $28.8 Million - $35 Million	-314,732 Reduced 1.57%	19,713,048 $2.15 Billion
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $23.4 Million - $29.9 Million	305,594 Added 1.55%	20,027,780 $1.83 Billion
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $1.24 Billion - $1.81 Billion	19,722,186 New	19,722,186 $1.56 Billion

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Abbott Laboratories Transaction History